1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Sankyo Co., Ltd.
  6. News
  7. MarketScreener Strategies
    6417   JP3326410002

SANKYO CO., LTD.

(6417)
  Report
Delayed Japan Exchange  -  01:25 2022-07-01 am EDT
4065.00 JPY   -0.97%
06/27AstraZeneca Partner Daiichi Sankyo Says EMA's Committee Backs Approval of Trastuzumab Deruxtecan to Treat Breast Cancer
MT
06/27AstraZeneca's Lynparza, Enhertu Win EU Panel's Backing for Approval in Breast Cancer
MT
06/27AstraZeneca-Daiichi Sankyo Enhertu Breast Cancer Drug Is Recommended for EU Approval
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sankyo Co., Ltd. : No turn-around in sight

06/23/2022 | 02:34am EDT
long trade
Live
Entry price : 4165¥ | Target : 4500¥ | Stop-loss : 3900¥ | Potential : 8.04%
The current trading zone is interesting to the point that investors should pay attention to the stock and anticipate a return of the underlying upward trend.
Investors have an opportunity to buy the stock and target the ¥ 4500.
Sankyo Co., Ltd. : Sankyo Co., Ltd. : No turn-around in sight
Summary
  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • According to Refinitiv, the company's ESG score for its industry is poor.

Strengths
  • The company's profit outlook over the next few years is a strong asset.
  • The company returns high margins, thereby supporting business profitability.
  • The company appears to be poorly valued given its net asset value.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • The opinion of analysts covering the stock has improved over the past four months.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart
Subsector Gambling & Gaming Machine Manufacturers
1st jan.Capitalization (M$)Investor Rating
SANKYO CO., LTD.39.72%1 769
LIGHT & WONDER, INC.-26.74%4 513
EVERI HOLDINGS INC.-23.23%1 511
UNIVERSAL ENTERTAINMENT COR..-41.17%814
POLLARD BANKNOTE LIMITED-47.45%437
AINSWORTH GAME TECHNOLOGY L..-26.36%220
PLAYAGS, INC.-24.01%191
More Results

© MarketScreener.com 2022

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials
Sales 2022 84 949 M 625 M 625 M
Net income 2022 17 538 M 129 M 129 M
Net Debt 2022 - - -
P/E ratio 2022 13,8x
Yield 2022 2,44%
Capitalization 238 B 1 753 M 1 753 M
Capi. / Sales 2022 2,80x
Capi. / Sales 2023 2,47x
Nbr of Employees 964
Free-Float 50,5%
Upcoming event on SANKYO CO., LTD.
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 4 105,00 JPY
Average target price 4 725,00 JPY
Spread / Average Target 15,1%
EPS Revisions
Managers and Directors
Akihiko Ishihara President, CEO & Representative Director
Hideyuki Busujima Chairman
Ichiro Tomiyama COO, Representative Director & Executive VP
Hiroshi Takahashi Managing Executive Officer & GM-Administration
Taro Kitani Independent Outside Director